Successfully Reducing Fat-modified Diet Duration for Treating Postoperative Chylothorax in Children

Area of Science:

• Pediatric Cardiology
• Thoracic Surgery
• Clinical Nutrition

Background:

• The standard treatment for chylothorax involves a fat-modified diet (FMD), typically for six weeks.
• The optimal duration of FMD to prevent chylothorax recurrence remains undetermined.
• This study investigated reducing FMD duration in pediatric postoperative chylothorax.

Purpose of the Study:

• To assess the efficacy of a shortened 2-week fat-modified diet (FMD) in managing pediatric postoperative chylothorax.
• To determine if reducing FMD duration increases the recurrence rate of chylothorax.
• To optimize treatment protocols for children with chylothorax after cardiac surgery.

Main Methods:

• A single-center study comparing preintervention (6-week FMD) and postintervention (2-week FMD) cohorts of pediatric patients.
• Exclusion of patients with cavopulmonary anastomoses.
• Definition of recurrence as chylous effusion requiring intervention or readmission within 30 days of diet resumption.

Main Results:

• The median FMD duration decreased significantly from 42 days to 26 days.
• No cases of chylothorax recurrence were observed in any treatment group.
• Compliance with the 2-week FMD protocol improved over time, reaching 79% in the latter period.

Conclusions:

• A 2-week fat-modified diet is a safe and effective duration for treating pediatric postoperative chylothorax.
• Shortening FMD duration to 2 weeks does not lead to an increased recurrence rate.
• This revised protocol simplifies management and can be implemented at the study center.